PCN59 THE POTENTIAL ECONOMIC BENEFITS PROVIDED BY COMBINING CISPLATIN WITH SRC INHIBITOR KX1-004 FOR CANCER REGIMENS
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72148-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)72148-3/fulltext
Section Title :
Section Order :
727
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72148-3&doi=10.1016/S1098-3015(10)72148-3